$965.21 Million in Sales Expected for H.B. Fuller (NYSE:FUL) This Quarter

Brokerages expect that H.B. Fuller (NYSE:FULGet Rating) will announce $965.21 million in sales for the current quarter, Zacks reports. Four analysts have issued estimates for H.B. Fuller’s earnings. The lowest sales estimate is $955.80 million and the highest is $973.37 million. H.B. Fuller reported sales of $827.87 million during the same quarter last year, which would suggest a positive year over year growth rate of 16.6%. The company is scheduled to issue its next quarterly earnings report on Monday, January 1st.

On average, analysts expect that H.B. Fuller will report full year sales of $3.79 billion for the current year, with estimates ranging from $3.74 billion to $3.83 billion. For the next year, analysts anticipate that the firm will report sales of $3.97 billion, with estimates ranging from $3.89 billion to $4.04 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of research analysts that cover H.B. Fuller.

H.B. Fuller (NYSE:FULGet Rating) last issued its quarterly earnings results on Wednesday, March 23rd. The specialty chemicals company reported $0.80 EPS for the quarter, topping the consensus estimate of $0.73 by $0.07. H.B. Fuller had a net margin of 5.39% and a return on equity of 12.40%. The firm had revenue of $856.50 million for the quarter, compared to analysts’ expectations of $817.92 million. During the same period in the previous year, the business earned $0.66 earnings per share. H.B. Fuller’s revenue for the quarter was up 18.0% compared to the same quarter last year.

FUL has been the topic of a number of analyst reports. Robert W. Baird raised H.B. Fuller from a “neutral” rating to an “outperform” rating and set a $85.00 price target on the stock in a research note on Thursday, April 14th. Zacks Investment Research cut H.B. Fuller from a “buy” rating to a “hold” rating in a research note on Friday, March 25th. Deutsche Bank Aktiengesellschaft raised H.B. Fuller from a “hold” rating to a “buy” rating and lifted their price target for the stock from $72.00 to $85.00 in a research note on Monday, April 18th. Citigroup dropped their price target on H.B. Fuller from $80.00 to $75.00 and set a “neutral” rating on the stock in a research note on Friday, March 25th. Finally, JPMorgan Chase & Co. cut H.B. Fuller from an “overweight” rating to a “neutral” rating and dropped their price target for the stock from $75.00 to $73.00 in a research note on Friday, January 21st. Five equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat, H.B. Fuller currently has an average rating of “Hold” and a consensus price target of $77.00.

In other H.B. Fuller news, VP Timothy J. Keenan sold 1,433 shares of H.B. Fuller stock in a transaction dated Friday, April 8th. The stock was sold at an average price of $68.25, for a total transaction of $97,802.25. Following the transaction, the vice president now owns 22,871 shares of the company’s stock, valued at approximately $1,560,945.75. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 4.69% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in FUL. Cramer Rosenthal Mcglynn LLC grew its stake in shares of H.B. Fuller by 21.3% in the 3rd quarter. Cramer Rosenthal Mcglynn LLC now owns 407,896 shares of the specialty chemicals company’s stock valued at $26,334,000 after buying an additional 71,523 shares in the last quarter. BNP Paribas Arbitrage SA grew its stake in shares of H.B. Fuller by 130.0% in the 3rd quarter. BNP Paribas Arbitrage SA now owns 56,816 shares of the specialty chemicals company’s stock valued at $3,668,000 after buying an additional 32,111 shares in the last quarter. Mutual of America Capital Management LLC grew its stake in shares of H.B. Fuller by 2.5% in the 4th quarter. Mutual of America Capital Management LLC now owns 7,179 shares of the specialty chemicals company’s stock valued at $581,000 after buying an additional 173 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of H.B. Fuller by 5.0% in the 4th quarter. Geode Capital Management LLC now owns 872,252 shares of the specialty chemicals company’s stock valued at $70,652,000 after buying an additional 41,376 shares in the last quarter. Finally, Credit Suisse AG grew its stake in shares of H.B. Fuller by 2.6% in the 4th quarter. Credit Suisse AG now owns 47,819 shares of the specialty chemicals company’s stock valued at $3,873,000 after buying an additional 1,228 shares in the last quarter. 96.93% of the stock is owned by institutional investors and hedge funds.

Shares of H.B. Fuller stock opened at $65.02 on Friday. The company has a current ratio of 1.87, a quick ratio of 1.11 and a debt-to-equity ratio of 1.15. The company’s 50-day moving average price is $67.34 and its two-hundred day moving average price is $72.00. H.B. Fuller has a 52 week low of $59.17 and a 52 week high of $81.73. The stock has a market cap of $3.45 billion, a PE ratio of 19.41 and a beta of 1.61.

The firm also recently announced a quarterly dividend, which was paid on Thursday, May 5th. Shareholders of record on Thursday, April 21st were paid a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a yield of 1.17%. The ex-dividend date was Wednesday, April 20th. This is a boost from H.B. Fuller’s previous quarterly dividend of $0.17. H.B. Fuller’s payout ratio is 22.69%.

About H.B. Fuller (Get Rating)

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products worldwide. The company operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.

Featured Articles

Get a free copy of the Zacks research report on H.B. Fuller (FUL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for H.B. Fuller (NYSE:FUL)

Receive News & Ratings for H.B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H.B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.